EMA Authorised: Torisel (temsirolimus) — Pfizer Europe MA EEIG

View source ↗

Summary

EMA authorised temsirolimus (Torisel) for renal cell carcinoma and mantle cell lymphoma in the EU, with Pfizer Europe MA EEIG as the marketing authorisation hol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma
• Renal Cell Carcinoma

Drugs mentioned

• Torisel (Temsirolimus)

Snippet

Status: Authorised. Therapeutic area: Carcinoma, Renal Cell;Lymphoma, Mantle-Cell. MAH: Pfizer Europe MA EEIG. Decision date: 25/02/2025